Shareholder Activist Litigation
The firm's Shareholder Activist Litigation Group has extensive experience in resolving disputes for corporate control, both hostile and friendly. Often collaborating with our Equity Investment & Activist Practice Group, which has been involved in proxy disputes in over 300 publicly trading companies, our Litigation Group is considered a nationwide leader in shareholder activist litigation, having appeared in courtrooms throughout the country on behalf of shareholder activists, corporate boards and acquisition candidates in sophisticated mergers and tender offers for public companies. When needed, we draw on deep and longstanding relationships with key players in the activist community including experts, Delaware counsel and proxy solicitation firms.
We routinely assist our activist clients in a range of matters, including enforcing shareholder rights to compel special and annual meetings, obtaining corporate records, obtaining shareholder lists, and challenging defensive maneuvers, in Shareholder Rights Plans, and Bylaws including poison pills and advance notice requirements. We also represent shareholders in responding to claims asserted in federal court, including claims by management alleging violations of federal securities laws involving proxy and reporting obligations, and in asserting derivative claims to challenge board conduct.
We are also called upon by corporate clients and their Boards to respond to claims by dissident shareholders seeking to enjoin mergers and tender offers, and to respond to unsolicited acquisition offers. We also have extensive experience in handling appraisal claims, having successfully recovered substantial sums on behalf of dissenting shareholders.
With decades of shareholder activist litigation experience in proxy and other contests for corporate control, our shareholder and corporate clients rely on us to develop strategies for transferring power that will reduce or eliminate the risk of litigation and avoid potential liability.
- January 3, 2020
- Olshan Obtains Injunction Blocking Proposed Three-Way Merger: Court of Chancery Finds that Conflicted Directors Breached Fiduciary Duties by Agreeing to Preclusive Deal Terms in an “Informational Vacuum”March 15, 2019
- February 12, 2018
- Olshan Client Richmond Brothers Scores Resounding Victory in Successful Proxy Contest at Rockwell MedicalJune 9, 2017